SP
The startup develops stem cell-derived in vitro models of the central nervous system using functionalized multi-arm polyethylene glycol monomers cross-linked with bioactive peptides to create hydrogels. These models provide researchers and clinicians with reliable cell-based assays for drug discovery and toxicology testing, addressing the need for more accurate disease modeling.
Updated 18 months ago
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SBFunding rounds are not available yet.
Founders
Product
Features
- The startup develops stem cell-derived in vitro models of the central nervous system using functionalized multi-arm polyethylene glycol monomers cross-linked with bioactive peptides to create hydrogels. These models provide researchers and clinicians with reliable cell-based assays for drug discovery and toxicology testing, addressing the need for more accurate disease modeling.